Fibrous dysplasia of the bone, The American Journal of Medicine, vol.44, issue.3, pp.421-429, 1968. ,
DOI : 10.1016/0002-9343(68)90112-5
Long-Term Effects of Intravenous Pamidronate in Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.41, issue.7, pp.1746-52, 1997. ,
DOI : 10.1359/jbmr.1997.12.10.1746
Pain in fibrous dysplasia of bone: age-related changes and the anatomical distribution of skeletal lesions, Osteoporosis International, vol.343, issue.1, pp.57-63, 2008. ,
DOI : 10.1007/s00198-007-0425-x
Physical function is impaired but quality of life preserved in patients with fibrous dysplasia of bone, Bone, vol.37, issue.3, pp.388-394, 2005. ,
DOI : 10.1016/j.bone.2005.04.026
Long-term effects of intravenous pamidronate in fibrous dysplasia of bone, The Lancet, vol.343, issue.8903, pp.953-957, 1994. ,
DOI : 10.1016/S0140-6736(94)90069-8
The effect of aging on the density of the sensory nerve fiber innervation of bone and acute skeletal pain, Neurobiology of Aging, vol.33, issue.5, pp.921-932, 2010. ,
DOI : 10.1016/j.neurobiolaging.2010.08.008
A phenotypically restricted set of primary afferent nerve fibers innervate the bone versus skin: Therapeutic opportunity for treating skeletal pain, Bone, vol.46, issue.2, pp.523-529, 2011. ,
DOI : 10.1016/j.bone.2009.09.013
Topographically Distinct Epidermal Nociceptive Circuits Revealed by Axonal Tracers Targeted to Mrgprd, Neuron, vol.45, issue.1, pp.17-25, 2005. ,
DOI : 10.1016/j.neuron.2004.12.015
Cancer pain and its impact on diagnosis, survival and quality of life, Nature Reviews Neuroscience, vol.5, issue.10, pp.797-809, 2006. ,
DOI : 10.1038/nrn1914
Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee, New England Journal of Medicine, vol.363, issue.16, pp.1521-1531, 2010. ,
DOI : 10.1056/NEJMoa0901510
Blockade of nerve sprouting and neuroma formation markedly attenuates the development of late stage cancer pain, Neuroscience, vol.171, issue.2, pp.588-598, 2010. ,
DOI : 10.1016/j.neuroscience.2010.08.056
A Blocking Antibody to Nerve Growth Factor Attenuates Skeletal Pain Induced by Prostate Tumor Cells Growing in Bone, Cancer Research, vol.65, issue.20, pp.9426-9435, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0826
Pathological Sprouting of Adult Nociceptors in Chronic Prostate Cancer-Induced Bone Pain, Journal of Neuroscience, vol.30, issue.44, pp.14649-14656, 2010. ,
DOI : 10.1523/JNEUROSCI.3300-10.2010
Mast cells differentially express and release active high molecular weight neurotrophins, Molecular Brain Research, vol.97, issue.2, pp.177-185, 2001. ,
DOI : 10.1016/S0169-328X(01)00314-X
Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones., Proceedings of the National Academy of Sciences, vol.90, issue.23, pp.10984-10988, 1993. ,
DOI : 10.1073/pnas.90.23.10984
Nerve growth factor expression and innervation of the painful intervertebral disc, The Journal of Pathology, vol.8, issue.(2), pp.286-292, 2002. ,
DOI : 10.1002/path.1108
Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis, Annals of the Rheumatic Diseases, vol.70, issue.3, pp.523-529, 2011. ,
DOI : 10.1136/ard.2010.137844
Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis, Annals of the Rheumatic Diseases, vol.66, issue.11, pp.1423-1428, 2007. ,
DOI : 10.1136/ard.2006.063354
Involvement of sensory nerves and immune cells in osteophyte formation in the ankle joint of adjuvant arthritic rats, Histochem Cell Biol, vol.118, pp.213-220, 2002. ,
An Instrument to Measure Skeletal Burden and Predict Functional Outcome in Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.38, issue.2, pp.219-226, 2005. ,
DOI : 10.1359/JBMR.041111
Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases, Pain, vol.17, issue.2, pp.197-210, 1983. ,
DOI : 10.1016/0304-3959(83)90143-4
Treatment of fibrous dysplasia of bone with intravenous pamidronate: long-term effectiveness and evaluation of predictors of response to treatment, Bone, vol.35, issue.1, pp.235-277, 2004. ,
DOI : 10.1016/j.bone.2004.03.004
The nonsurgical treatment of fibrous dysplasia, Rev Rhum Engl Ed, vol.66, issue.1, pp.1-3, 1999. ,
Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia, Bone, vol.33, issue.4, pp.582-590, 2003. ,
DOI : 10.1016/S8756-3282(03)00221-7
Long-Term Aminobisphosphonate Treatment of Fibrous Dysplasia: Spectacular Increase in Bone Density, Journal of Bone and Mineral Research, vol.343, issue.8, pp.1314-1319, 1997. ,
DOI : 10.1359/jbmr.1997.12.8.1314
Oral alendronate treatment for polyostotic fibrous dysplasia: a case report, Journal of Orthopaedic Science, vol.9, issue.5, pp.521-526, 2004. ,
DOI : 10.1007/s00776-004-0809-0
Bisphosphonate Therapy in Fibrous Dysplasia, Clinical Orthopaedics and Related Research, vol.382, pp.6-12, 2001. ,
DOI : 10.1097/00003086-200101000-00003
Medical Therapy in Adults With Fibrous Dysplasia of Bone, Journal of Bone and Mineral Research, vol.20, issue.S2, pp.114-123, 2006. ,
DOI : 10.1359/jbmr.06s222
Effect of Pamidronate Treatment in Children with Polyostotic Fibrous Dysplasia of Bone, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.10, pp.4569-75, 2003. ,
DOI : 10.1210/jc.2003-030050
Pamidronate treatment of bone fibrous dysplasia in nine children with McCune-Albright syndrome, Acta Paediatrica, vol.187, issue.2, pp.188-93, 2000. ,
DOI : 10.1111/j.1651-2227.2000.tb01214.x
Bone Turnover in Children and Adolescents with McCune-Albright Syndrome Treated with Pamidronate for Bone Fibrous Dysplasia, Calcified Tissue International, vol.71, issue.2, pp.71121-71129, 2002. ,
DOI : 10.1007/s00223-001-1098-7
Intravenous pamidronate treatment of polyostotic fibrous dysplasia associated with the McCune Albright syndrome, The Journal of Pediatrics, vol.137, issue.3, pp.403-412, 2000. ,
DOI : 10.1067/mpd.2000.107836
Age-dependent demise of GNAS-mutated skeletal stem cells and " normalization " of fibrous dysplasia of bone, J Bone Miner Res, issue.11, pp.231741-231781, 2008. ,
Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome., Journal of Clinical Investigation, vol.98, issue.1, pp.30-35, 1996. ,
DOI : 10.1172/JCI118773
Osteoclastogenesis in fibrous dysplasia of bone: in situ and in vitro analysis of IL-6 expression, Bone, vol.33, issue.3, pp.434-476, 2003. ,
DOI : 10.1016/S8756-3282(03)00064-4
Rapid and sustained improvement in bone and cartilage turnover markers with the anti??????interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone, Arthritis & Rheumatism, vol.32, issue.1, pp.33-43, 2010. ,
DOI : 10.1002/art.25053